Rahul Banerjee, MD, FACP

About Dr. Rahul Banerjee

Dr. Rahul Banerjee is a physician and researcher specializing in multiple myeloma, a blood cancer that affects plasma cells and can lead to bone and kidney complications. He also treats patients with AL amyloidosis, a related but less common condition that requires a multidisciplinary approach involving specialists in oncology, nephrology, and cardiology.

His research focuses on cellular immunotherapies, particularly chimeric antigen receptor T-cell therapy, in which a patient’s immune cells are genetically engineered to identify and destroy cancerous cells. As a member of the International Myeloma Working Group, Dr. Banerjee has contributed extensively to the field, authoring more than 70 peer-reviewed publications. His work emphasizes improving the treatment experience and quality of life for individuals undergoing therapy for multiple myeloma.